Search research articles
Contact Us
Filters
Showing results (111-120 of 621) with videos related to
Page
of 63
Sort By:
Drugs
|
March 30, 2011
Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer
Branislav Bystricky, Alicia F C Okines, David Cunningham
The International Journal on Drug Policy
|
July 26, 2016
Supportive housing and surveillance
Jade Boyd, David Cunningham, Solanna Anderson, et al.
Lancet (London, England)
|
July 7, 2018
Is organ preservation in rectal cancer ready for prime time?
Paris Tekkis, Diana Tait, David Cunningham, et al.
The New England Journal of Medicine
|
March 5, 2010
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham, Alicia F C Okines, Sue Ashley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2014
Optimal management of esophageal adenocarcinoma: should we be CROSS?
Elizabeth C Smyth, Tom S Waddell, David Cunningham
Human Genetics
|
August 31, 2017
SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities
Catherine E Dominguez, David Cunningham, Dawn S Chandler
Therapeutic Advances in Gastroenterology
|
September 5, 2013
The role of personalized medicine in metastatic colorectal cancer: an evolving landscape
Sing Yu Moorcraft, Elizabeth C Smyth, David Cunningham
Cureus
|
February 6, 2016
Long-term Disease-free Survival Following Combination Multi-visceral and Metastatic Resection with Neoadjuvant FOLFIRINOX for Pancreatic Adenocarcinoma: A Case Report
Mikael Sodergren, Kirsty Brammer, David Cunningham, et al.
Therapeutic Advances in Medical Oncology
|
July 24, 2018
The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
Michael Flynn, Kate Young, David Cunningham, et al.
Journal of the National Cancer Institute
|
January 13, 2016
Response
Francesco Sclafani, David Cunningham, Clare Peckitt, et al.
Page
of 63
Search research articles
Search
Showing results (111-120 of 621) with videos related to
Sort By:
Page
of 63
Drugs
|
March 30, 2011
Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer
Branislav Bystricky, Alicia F C Okines, David Cunningham
The International Journal on Drug Policy
|
July 26, 2016
Supportive housing and surveillance
Jade Boyd, David Cunningham, Solanna Anderson, et al.
Lancet (London, England)
|
July 7, 2018
Is organ preservation in rectal cancer ready for prime time?
Paris Tekkis, Diana Tait, David Cunningham, et al.
The New England Journal of Medicine
|
March 5, 2010
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham, Alicia F C Okines, Sue Ashley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2014
Optimal management of esophageal adenocarcinoma: should we be CROSS?
Elizabeth C Smyth, Tom S Waddell, David Cunningham
Human Genetics
|
August 31, 2017
SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities
Catherine E Dominguez, David Cunningham, Dawn S Chandler
Therapeutic Advances in Gastroenterology
|
September 5, 2013
The role of personalized medicine in metastatic colorectal cancer: an evolving landscape
Sing Yu Moorcraft, Elizabeth C Smyth, David Cunningham
Cureus
|
February 6, 2016
Long-term Disease-free Survival Following Combination Multi-visceral and Metastatic Resection with Neoadjuvant FOLFIRINOX for Pancreatic Adenocarcinoma: A Case Report
Mikael Sodergren, Kirsty Brammer, David Cunningham, et al.
Therapeutic Advances in Medical Oncology
|
July 24, 2018
The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
Michael Flynn, Kate Young, David Cunningham, et al.
Journal of the National Cancer Institute
|
January 13, 2016
Response
Francesco Sclafani, David Cunningham, Clare Peckitt, et al.
Page
of 63